CBLN1 and Parkinson disease: Our analysis also revealed notable reductions in the levels of various abundant Cer species in the SNpc of patients with PD relative to the levels observed in other areas of the brain and control SNpc, particularly those linked to long-chain FAs (Fig. 1B).